Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.
Saved in:
| Title: | Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. |
|---|---|
| Authors: | Chabon JJ; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA., Simmons AD; Clovis Oncology, Inc., San Francisco, California 94158, USA., Lovejoy AF; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA., Esfahani MS; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA., Newman AM; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA., Haringsma HJ; Clovis Oncology, Inc., San Francisco, California 94158, USA., Kurtz DM; Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305, USA.; Department of Bioengineering, Stanford University, Stanford, California 94305, USA., Stehr H; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA., Scherer F; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA.; Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305, USA., Karlovich CA; Clovis Oncology, Inc., San Francisco, California 94158, USA., Harding TC; Clovis Oncology, Inc., San Francisco, California 94158, USA., Durkin KA; Molecular Graphics and Computation Facility, College of Chemistry, University of California, Berkeley, California 94720, USA., Otterson GA; The Ohio State University, Columbus, Ohio 43210, USA., Purcell WT; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado 80045, USA., Camidge DR; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado 80045, USA., Goldman JW; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095, USA., Sequist LV; Massachusetts General Hospital &Harvard Medical School, Boston, Massachusetts 02115, USA., Piotrowska Z; Massachusetts General Hospital &Harvard Medical School, Boston, Massachusetts 02115, USA., Wakelee HA; Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305, USA., Neal JW; Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305, USA., Alizadeh AA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA.; Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305, USA.; Division of Hematology, Department of Medicine, Stanford University, Stanford, California 94305, USA., Diehn M; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA.; Department of Radiation Oncology, Stanford University, Stanford, California 94305, USA. |
| Source: | Nature communications [Nat Commun] 2016 Jun 10; Vol. 7, pp. 11815. Date of Electronic Publication: 2016 Jun 10. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27283993 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chabon+JJ%22">Chabon JJ</searchLink>; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA.<br /><searchLink fieldCode="AU" term="%22Simmons+AD%22">Simmons AD</searchLink>; Clovis Oncology, Inc., San Francisco, California 94158, USA.<br /><searchLink fieldCode="AU" term="%22Lovejoy+AF%22">Lovejoy AF</searchLink>; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA.<br /><searchLink fieldCode="AU" term="%22Esfahani+MS%22">Esfahani MS</searchLink>; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA.<br /><searchLink fieldCode="AU" term="%22Newman+AM%22">Newman AM</searchLink>; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA.<br /><searchLink fieldCode="AU" term="%22Haringsma+HJ%22">Haringsma HJ</searchLink>; Clovis Oncology, Inc., San Francisco, California 94158, USA.<br /><searchLink fieldCode="AU" term="%22Kurtz+DM%22">Kurtz DM</searchLink>; Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305, USA.; Department of Bioengineering, Stanford University, Stanford, California 94305, USA.<br /><searchLink fieldCode="AU" term="%22Stehr+H%22">Stehr H</searchLink>; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA.<br /><searchLink fieldCode="AU" term="%22Scherer+F%22">Scherer F</searchLink>; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA.; Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305, USA.<br /><searchLink fieldCode="AU" term="%22Karlovich+CA%22">Karlovich CA</searchLink>; Clovis Oncology, Inc., San Francisco, California 94158, USA.<br /><searchLink fieldCode="AU" term="%22Harding+TC%22">Harding TC</searchLink>; Clovis Oncology, Inc., San Francisco, California 94158, USA.<br /><searchLink fieldCode="AU" term="%22Durkin+KA%22">Durkin KA</searchLink>; Molecular Graphics and Computation Facility, College of Chemistry, University of California, Berkeley, California 94720, USA.<br /><searchLink fieldCode="AU" term="%22Otterson+GA%22">Otterson GA</searchLink>; The Ohio State University, Columbus, Ohio 43210, USA.<br /><searchLink fieldCode="AU" term="%22Purcell+WT%22">Purcell WT</searchLink>; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado 80045, USA.<br /><searchLink fieldCode="AU" term="%22Camidge+DR%22">Camidge DR</searchLink>; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado 80045, USA.<br /><searchLink fieldCode="AU" term="%22Goldman+JW%22">Goldman JW</searchLink>; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095, USA.<br /><searchLink fieldCode="AU" term="%22Sequist+LV%22">Sequist LV</searchLink>; Massachusetts General Hospital &Harvard Medical School, Boston, Massachusetts 02115, USA.<br /><searchLink fieldCode="AU" term="%22Piotrowska+Z%22">Piotrowska Z</searchLink>; Massachusetts General Hospital &Harvard Medical School, Boston, Massachusetts 02115, USA.<br /><searchLink fieldCode="AU" term="%22Wakelee+HA%22">Wakelee HA</searchLink>; Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305, USA.<br /><searchLink fieldCode="AU" term="%22Neal+JW%22">Neal JW</searchLink>; Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305, USA.<br /><searchLink fieldCode="AU" term="%22Alizadeh+AA%22">Alizadeh AA</searchLink>; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA.; Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305, USA.; Division of Hematology, Department of Medicine, Stanford University, Stanford, California 94305, USA.<br /><searchLink fieldCode="AU" term="%22Diehn+M%22">Diehn M</searchLink>; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, California 94305, USA.; Department of Radiation Oncology, Stanford University, Stanford, California 94305, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2016 Jun 10; Vol. 7, pp. 11815. <i>Date of Electronic Publication: </i>2016 Jun 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27283993 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/ncomms11815 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 11815 Titles: – TitleFull: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chabon JJ – PersonEntity: Name: NameFull: Simmons AD – PersonEntity: Name: NameFull: Lovejoy AF – PersonEntity: Name: NameFull: Esfahani MS – PersonEntity: Name: NameFull: Newman AM – PersonEntity: Name: NameFull: Haringsma HJ – PersonEntity: Name: NameFull: Kurtz DM – PersonEntity: Name: NameFull: Stehr H – PersonEntity: Name: NameFull: Scherer F – PersonEntity: Name: NameFull: Karlovich CA – PersonEntity: Name: NameFull: Harding TC – PersonEntity: Name: NameFull: Durkin KA – PersonEntity: Name: NameFull: Otterson GA – PersonEntity: Name: NameFull: Purcell WT – PersonEntity: Name: NameFull: Camidge DR – PersonEntity: Name: NameFull: Goldman JW – PersonEntity: Name: NameFull: Sequist LV – PersonEntity: Name: NameFull: Piotrowska Z – PersonEntity: Name: NameFull: Wakelee HA – PersonEntity: Name: NameFull: Neal JW – PersonEntity: Name: NameFull: Alizadeh AA – PersonEntity: Name: NameFull: Diehn M IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 06 Text: 2016 Jun 10 Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 7 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |